Download FREE Report Sample
Download Free sampleInfectious Disease Rapid Diagnostic Testing Market contains market size and forecasts of Infectious Disease Rapid Diagnostic Testing in Global, including the following market information:
Global Infectious Disease Rapid Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Disease Rapid Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Assays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Rapid Diagnostic Testing include Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc. and Mesa Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Disease Rapid Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Rapid Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Assays
Platforms
Global Infectious Disease Rapid Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Respiratory Infection
Gastro-Intestinal Infection
Center Nervous System Infection
Hospital Acquired Infection
Sexually Transmitted Infections
Others
Global Infectious Disease Rapid Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Rapid Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Disease Rapid Diagnostic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Roche Ltd
Danaher Corporation
Luminex Corporation
BGI Group
bioMerieux S.A.
DiaSorin S.p.A
Hologic, Inc.
Mesa Biotech
Quidel Corporation
Thermo Fisher Scientific Inc.
GenMark Diagnostics
CTK Biotech
Becton Dickinson
Cellex Inc.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
